Industry Briefs: Feb. 27, 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Industry Briefs: Feb. 27, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.


Company News

Almac has acquired two pieces of encapsulation equipment for its North American headquarters in Souderton, Pennsylvania. Read More

Angiochem and GlaxoSmithKline have formed a collaboration to discover, develop, and commercialize treatments for lysosomal storage diseases. Read More

Auxilium Pharmaceuticals and Actelion Pharmaceuticals have formed a collaboration agreement for Xiaflex (collagenase clostridium histolyticum). Read More

BASF has launched a white biotechnology and microbiology research laboratory at its Tarrytown, New York, facility. Read More

Boehringer Ingelheim and Xencor have formed a collaboration agreement for the development, manufacture, and supply of biosuperior monoclonal antibodies. Read More

EMD Millipore has partnered with Charles River Laboratories for viral-clearance studies. Read More

In other news, EMD Millipore has opened its first laboratory water-production site in China. Read More

Haupt Pharma and the Fraunhofer Institute optimize Haupt’s supply-chain capabilities. Read More

Hospira has joined the Generic Pharmaceutical Association (GPhA). Read More

Penn Pharma plans a £14-million ($22.2 million) investment in its South Wales, United Kingdom, facility to increase its global supply and its high-containment manufacturing capabilities. Read More

Pfizer has acquired Alacer, a vitamin supplements company. Read More

Roche has extended its tender offer for Illumina. Read More

Sol-Gel has signed a $24.7-million agreement with an undisclosed pharmaceutical company for the development and commercialization in the United States and Canada of a dermatologic drug. Read More

People News

Amarillo Biosciences has appointed Stephen Chen as chairman and CEO. Joseph Cummins will remain as president and chief operating officer. Read More

DPT Laboratories has named Kuljit Bhatia as vice-president of R&D. Read More

Johnson & Johnson’s (J&J) board of directors has named Alex Gorsky to succeed Bill Weldon as CEO, effective Apr. 26, 2012. Gorsky was also nominated for election to the board of directors at J&J’s annual meeting of shareholders. Read More

Mylan North America President Tony Mauro has been elected chairman of GPhA. Read More

OSO BioPharmaceuticals has appointed Marian Meyer as director of laboratories. Read More

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
44%
Facility/environment problems
0%
Process development problems
11%
Production equipment downtime
11%
Raw material supply problems
11%
Regulatory restrictions
0%
Business decisions to limit production
22%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Patent Settlements Become More Risky
Praise and Perils for Biotechnology Patent Policy
Risk-Mitigation Strategies in Drug Manufacturing for Emerging Markets
Quality Focus: Ensuring Raw Material Transparency
Advertising of Prescription Drugs  Keeping it Honest and Balanced

Click here